Posts

Showing posts from February, 2025

In Venture Veritas: True Stories of Inventing Technologies and Making Great Wine | LSI USA '24

Image
Gabriel Jones, Josh Makower, and Cameron Myhrvold discussed the parallels between tech innovation and winemaking. They shared stories of creative problem-solving, the importance of adaptability, and much more. For more information visit our website https://www.lifesciencemarketresearch.com/videos

The Weekly Recap 2/21/25: LSI Alumni Achievements Driving Medtech and Healthtech Forward

  In a successful week for the medical technology companies in the LSI Alumni community, we saw LSI Alumni secure over $174M in new funding, obtain regulatory approval, enter new strategic partnerships, and much more on the road to   LSI USA  ’25 in Dana Point, CA (March 17–21). Accelus Promoted Jim Fox to Vice President of U.S. Sales, expanding his leadership role in driving nationwide commercial growth. Fox, who previously led sales in the Eastern U.S., will focus on strengthening distributor partnerships and increasing adoption of Accelus’s expandable spinal implant technologies. Approxima Secured €7.3M in the first closing of its Series A financing round to advance its percutaneous right ventricular reshaping technology for tricuspid valve regurgitation. The funds will support preclinical verification, first-in-human trials, and a U.S. Early Feasibility Study. Berlin Heals Secured over CHF 7M in funding to support first-in-human studies for less invasive implant appro...

LSI Alumni Funding Report January 2025

January was another impressive month of funding for the LSI Alumni, raising over $500 million in new capital across 12 new deals. Our monthly Alumni Funding Update features transactions made by these medical device startups and their investors, as well as links to our proprietary media and coverage of the companies themselves. For more information visit  https://www.slideshare.net/slideshow/lsi-alumni-funding-report-january-2025/275811111

Spine Devices Market: Stryker’s Strategic Exit and Industry Trends

The spine devices market is undergoing significant changes, with key players adapting their strategies in response to shifting industry dynamics. One such notable development comes from Stryker, which recently made a strategic exit by selling its U.S. spinal implants business to Viscogliosi Bros., LLC, a family investment firm focused on neuro-musculoskeletal technology. This deal also includes a bid to acquire Stryker’s spinal products in France and the formation of VB Spine, LLC, which will have exclusive access to Stryker’s robotic Mako Spine and Copilot portfolio for use with its implants. This move reflects a shift in Stryker’s strategy within the competitive market. With increased competition and slow market growth, Stryker has decided to reassess its position in the spine segment and refocus its resources on other areas with higher growth potential. This article will delve into the strategic reasoning behind this deal and its implications for the spine devices market. The Spine ...

Foot and Ankle Devices Market: Zimmer Biomet Makes $1.2B Move

The medtech industry is off to a fast start in 2025, with Zimmer Biomet making a major acquisition that is set to reshape its position in the foot and ankle devices market. This week, the orthopedic giant announced its decision to acquire Paragon 28 for $1.2 billion, marking a significant shift in Zimmer Biomet’s strategic focus. In this blog, we’ll break down how this deal strengthens Zimmer Biomet’s foothold in the foot and ankle space, examine the growing potential of the foot and ankle devices market, and explore the numbers highlighting why this market is becoming increasingly important for companies like Zimmer Biomet. A Strong Move in Foot and Ankle Devices Founded in 2010, Paragon 28 has positioned itself as a leader in the foot and ankle space, focusing on developing and commercializing surgical implants for various foot and ankle conditions. This includes addressing deformities, fractures, joint replacements, and trauma. Paragon 28’s business model is built around a portfolio...

The Weekly Recap 2/7/25: LSI Alumni Achievements Driving Medtech and Healthtech Forward

In a successful week for the medical technology companies in the LSI Alumni community, we saw LSI Alumni launch new products, secure regulatory approvals, appoint new executives, and much more on the road to  LSI USA  ’25 in Dana Point, CA (March 17–21). Arsenal Medical Completed enrollment of an initial cohort of ten patients in its EMBO-02 clinical study of NeoCast to treat chronic subdural hematoma (cSDH). Neocast is a solvent-free, non-adhesive liquid embolic agent designed for effective deep distal penetration. Cagent Vascular Announced the launch of its most recent product, Serranator SL-PRO PTA Serration Balloon Catheter. The Serranator SL-PRO is specifically designed for pedal interventions and challenging-to-cross tibial disease. CereVasc Shared the initial results of its pilot clinical study evaluating the eShunt System for elderly patients with normal pressure hydrocephalus (NPH). The data supports the system’s potential as a minimally invasive alternative to tradit...

GI Endoscopy Procedures of the Stomach and Small Intestine

GI endoscopy procedures of the stomach and small intestine have become a cornerstone in diagnosing and treating a breadth of GI conditions. These procedures play a critical role in patient care, offering less invasive options to traditional surgery and enabling more accurate diagnosis and treatment. With a growing demand for these procedures, fueled by rising rates of chronic GI conditions and technological advancements, the global volume of endoscopic procedures continues to rise. This article delves into the current landscape of the   GI endoscopy market , exploring its historical roots, the driving forces behind its growth, and the future outlook for these essential procedures. The Evolution and Significance of GI Endoscopy Procedures Historically, the development of GI endoscopy procedures began to provide physicians with a less invasive method to examine the digestive tract. These procedures have evolved from basic examinations to advanced diagnostic tools that can now also pe...

The Memo: NousQ Revolutionizing Ear Tube Insertion

  Under the direction of Founder and CEO Lynne Lim, NousQ is revolutionizing the treatment of middle ear infections with CLiKX, a novel robotic handheld device designed to make effective care accessible to patients worldwide. This innovative device reimagines treatment by reducing the need for complex surgical infrastructure and general anesthesia, bringing a much-needed solution to millions of patients in both developed and developing regions. Origin Story The inspiration for CLiKX arose during a pivotal moment in Lim’s career while on a humanitarian mission in Cambodia. As part of a surgical outreach program, Lim performed free surgeries for children, including the removal of a large neck tumor using only local anesthesia. However, an encounter with hundreds of children suffering from middle ear infections left a profound impact on her. “These kids had trekked for days over mountains to see me, thinking I could help them,” Lim recalled. “But without an operating theater, general ...